Evaluation and Validation of Endogenous Markers for the Assessment of CYP3A Activity in Korean Healthy Subjects Using Metabolomics

NCT02579434 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Midazolam I.V.

Sponsor

Seoul National University Hospital